Ligand validation:8UFU

BTB: 2-[BIS-(2-HYDROXY-ETHYL)-AMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8UFU_BTB_B_504	58%	70%	0.144	0.921	0.55	0.6	-	-	0	0	100%	1
8UFU_BTB_A_504	55%	67%	0.132	0.898	0.52	0.76	-	-	2	0	100%	1
8UFU_BTB_C_504	53%	42%	0.142	0.901	0.68	1.53	-	2	0	0	100%	1
8UFU_BTB_B_505	38%	62%	0.209	0.914	0.52	0.94	-	-	2	0	100%	1
8UFU_BTB_D_503	35%	64%	0.196	0.885	0.42	0.95	-	-	1	0	100%	1
8UFU_BTB_D_504	29%	62%	0.197	0.857	0.52	0.92	-	-	0	0	100%	1
8UFU_BTB_A_505	20%	81%	0.203	0.805	0.37	0.45	-	-	0	0	100%	1
8UFU_BTB_C_505	11%	73%	0.207	0.723	0.37	0.67	-	-	1	0	100%	1
6PP3_BTB_B_509	82%	66%	0.115	0.972	0.36	0.94	-	1	1	0	100%	1
7TSH_BTB_C_504	82%	67%	0.124	0.981	0.5	0.75	-	-	0	0	100%	1
6NH8_BTB_C_504	82%	76%	0.113	0.967	0.38	0.57	-	-	2	0	100%	1
5VVB_BTB_A_504	77%	77%	0.13	0.97	0.36	0.55	-	-	2	0	100%	1
7TSL_BTB_A_504	77%	60%	0.115	0.954	0.41	1.1	-	-	2	0	100%	1
5O5D_BTB_A_604	100%	59%	0.022	0.994	0.89	0.68	1	-	2	0	100%	1
5O59_BTB_A_605	99%	76%	0.057	0.987	0.52	0.44	-	-	2	0	100%	1
2OB3_BTB_A_906	98%	13%	0.06	0.986	2.82	1.16	4	1	0	0	100%	1
9FZ6_BTB_C_902	98%	69%	0.07	0.989	0.83	0.37	-	-	1	0	100%	0.2
2OQL_BTB_B_701	95%	63%	0.066	0.969	0.66	0.75	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.